Apple Watch-led Surveillance of AF Recurrence After Catheter Ablation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

Also called NCT05016791

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 172 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05016791
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05016791. Randomized; no masking; primary purpose diagnostic. Start 2022-01-26 (actual); primary completion 2024-08-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Apple Watch-led Surveillance of AF Recurrence After Catheter Ablation
Acronym
AFFU-AW
Intervention (Device)
Apple Watch-based heart rhythm monitoring
Lead sponsor
Barts & The London NHS Trust (class: other)

Record details

Record id
cardio:ct-nct05016791
Content hash
734d412539a8dae9270da2680406b093207567062eb19bb41afae26ee0929ba7